Hello, a clarification on how teams are invited to the Prospective phase. The challenge page says: "The top 10 participants from the retrospective phase will be invited to advance to the prospective phase where they will each purchase 50 compounds in-stock at Enamine". The Incentives page says: "The top 5 groups from the Blind test step and the top 5 groups from the Active learning step will be invited to take part in the Prospective phase of the challenge." Could you confirm: 1. How the 10 invitations are apportioned between the Blind test step and the Active learning step (five per step, or one combined retrospective ranking), and how a team placing in both is counted? 2. Whether a team outside the top 5 of each step individually may still submit its list of 50 compounds to the Prospective evaluation queue during the 1 November - 15 December round? Thank you.

Created by Vũ Mai VBDI_Bio_FEx_TeamVNG
Hello @VBDI_Bio_FEx_TeamVNG, 1. We are going to invite groups ranking in the top5 in the Blind Test step and in the top5 in the Active Learning step. In case of overlaps between the rankings or participants not accepting the invitation, we might redistributed the invitations to other teams based on the official leaderboard. These additional invitations are fully discretionary and do not follow an automatic mechanism. 2. The Prospective Phase is invitation only. Purchasing the compounds and experimentally testing them requires a significant investment in funds and time for us, for this reason we can only accept a finite number of submissions in the Prospective Phase. Only submissions from invited teams will be considered, all other submissions will be ignored.

Prospective phase: how are the 10 invitations apportioned between the Blind test and Active learning steps? page is loading…